Quantcast

Latest Cancer immunotherapy Stories

2013-08-27 23:01:29

The Society for Immunotherapy of Cancer (SITC) Consensus Statement on Tumor Immunotherapy for the Treatment of Cutaneous Melanoma was created to address the lack of information about when and how to implement cancer immunotherapy by practicing clinical oncologists and related health care providers. Milwaukee, WI (PRWEB) August 27, 2013 The first evidence-based consensus statement on tumor immunotherapy for the treatment of patients with melanoma has been released by the Society for...

2013-08-19 13:10:09

In animal studies, CHOP researchers advance new approach to anti-tumor immunotherapy By carefully adjusting the function of crucial immune cells, scientists may have developed a completely new type of cancer immunotherapy—harnessing the body's immune system to attack tumors. To accomplish this, they had to thread a needle in immune function, shrinking tumors without triggering unwanted autoimmune responses. The new research, performed in animals, is not ready for clinical use in...

2013-07-11 16:28:34

Cancer vaccines prime the immune system to attack cancer cells, decreasing tumor progression. IL-12p70, a molecule produced by certain types of immune cells, has been shown to reduce tumor progression, but delivering it as part of a cancer vaccine has been limited because of its toxicity in high doses. In the current issue of the Journal of Clinical Investigation, Dr. Beatriz Carreno and colleagues at Washington University report the results of a clinical trial that tested a vaccine to treat...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related